SCHEMBL6813709

SCHEMBL6813709

CCCC(=O)Oc1ccc2c(c1)CC(C)(C=O)N2C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL9 O00512 1/20 0.36
CTNNB1 P35222 1/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GLA P06280 2/20 0.34
GAA P10253 2/20 0.34
KMT2A Q03164 2/20 0.34
CA2 P00918 2/20 0.33
HPGD P15428 2/20 0.32
MAPT P10636 1/20 0.32
HIF1A Q16665 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32
P2RX3 P56373 1/20 0.31
ACHE P22303 2/20 0.30
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813708 0.74 ALDH1A1 (0.34) BCL9CTNNB1KDM4EALDH1A1GLA
SCHEMBL7169094 0.68 TP53 (0.40) ALDH1A1GAAKMT2AMAPTMEN1
SCHEMBL6814026 0.65 NOD1 (0.41) GAAKMT2AMAPT
SCHEMBL3639828 0.62 NR1H2 (0.46) KDM4EALDH1A1GAAKMT2AMAPT
SCHEMBL3448269 0.62 RBP4 (0.36) ALDH1A1KMT2A
SCHEMBL11023644 0.62 BCL9 (0.70) BCL9CTNNB1KDM4EALDH1A1GLA
SCHEMBL3686615 0.61 ATM (0.60) BCL9CTNNB1KDM4EALDH1A1GLA
SCHEMBL28518145 0.61 KMT2A (0.49) BCL9CTNNB1KDM4EALDH1A1GLA
SCHEMBL27805290 0.61 MAOB (0.49) BCL9CTNNB1KDM4EALDH1A1GLA
SCHEMBL28611141 0.60 PDGFRB (0.52) BCL9CTNNB1KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825225-B2 useful against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci and streptococci, anaerobic organisms such as bacteroides and clostridia species, and acid-fast organisms PHARMACIA & UPJOHN COMPANY 2004-11-30 US disclosed
US-20040116413-A1 Novel bicyclic isoxazolinones as antibacterial agents PHARMACIA & UPJOHN COMPANY 2004-06-17 US disclosed